Study 2 of 2Orforglipron (LY-3502970) literatureLancet (London, England) · Phase 3Top journal2026
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial.
Not reported in abstract.
Where it sits
this study against the rest of the orforglipron (ly-3502970) corpus1
Preclinical · this one
0
Observational
0
Open-label
0
Randomised
1
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
Phase 32026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.